Connor, Clark & Lunn Investment Management Ltd. Voyager Therapeutics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$7.15 - $10.84 $176,411 - $267,455	24,673 New	24,673 $229,000
Q3 2023 Nov 13, 2023	SELL	$7.55 - $11.25 $563,109 - $839,070	-74,584 Reduced 67.19%	36,425 $282,000
Q2 2023 Aug 10, 2023	BUY	$6.94 - $13.99 $1,325 - $2,672	191 Added 0.17%	111,009 $1.27 Million
Q1 2023 May 09, 2023	SELL	$6.0 - $10.78 $33,522 - $60,227	-5,587 Reduced 4.8%	110,818 $854,000
Q4 2022 Feb 10, 2023	BUY	$4.94 - $6.61 $20,995 - $28,092	4,250 Added 3.79%	116,405 $710,000
Q3 2022 Nov 10, 2022	SELL	$5.57 - $7.47 $44,983 - $60,327	-8,076 Reduced 6.72%	112,155 $664,000
Q2 2022 Aug 05, 2022	SELL	$4.82 - $10.09 $64,303 - $134,610	-13,341 Reduced 9.99%	120,231 $711,000
Q1 2022 May 12, 2022	SELL	$2.75 - $9.44 $38,395 - $131,801	-13,962 Reduced 9.46%	133,572 $1.02 Million
Q4 2021 Feb 10, 2022	BUY	$2.47 - $5.55 $285,047 - $640,492	115,404 Added 359.18%	147,534 $400,000
Q3 2021 Nov 12, 2021	BUY	$2.63 - $4.12 $84,501 - $132,375	32,130 New	32,130 $85,000
Q2 2020 Aug 13, 2020	SELL	$8.05 - $14.21 $212,520 - $375,144	-26,400 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$6.8 - $14.66 $17,931 - $38,658	2,637 Added 11.1%	26,400 $241,000
Q4 2019 Feb 12, 2020	BUY	$12.82 - $16.85 $304,641 - $400,406	23,763 New	23,763 $331,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

Black Rock Inc. New York, NY

5.31M
Shares

$30.7 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.2M
Shares

$30.1 Million
0.5% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.92M
Shares

$22.6 Million
0.99% of portfolio
Vanguard Group Inc Valley Forge, PA

3.19M
Shares

$18.4 Million
0.0% of portfolio
Farallon Capital Management LLC San Francisco, CA

2.29M
Shares

$13.2 Million
0.07% of portfolio

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account